BLINCYTO*
- Blinatumomab - Blincyto- @- (Mar 2014 and July 2017 ) - Anti-cancer
Compositions:
Bilnatumomab- mg,
List of Related Indications:
Bilnatumomab- mg,
- For the treatment of Philadelphia Chromosome-Negative relapsed or Refractory B-cell precusor acute Lymphpblastic Leukemia(R/R ALL)
Strength | Rate | Packing Style |
---|---|---|
mg | 0.00 | unit |